Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes

Post-transplant lymphoproliferative disease (PTLD) represents a serious complication following allogeneic hematopoietic stem cell transplantation (alloHSCT). Previously, survival rates of PTLD have improved due to the introduction of rituximab. However, reports on curative management of refractory P...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Med (Lausanne)
Hoofdauteurs: Mika, Thomas, Strate, Katharina, Ladigan, Swetlana, Aigner, Clemens, Schlegel, Uwe, Tischoff, Iris, Tischer-Zimmermann, Sabine, Eiz-Vesper, Britta, Maecker-Kolhoff, Britta, Schroers, Roland
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2019
Onderwerpen:
Medicine
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930172/
https://ncbi.nlm.nih.gov/pubmed/31921871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00295
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items